Skip to main content

Advertisement

Table 2 Comparison of the proportional HIV risk group distribution in the participating countries of the SPREAD study with proportional HIV risk group distribution collected in 2007 by the European Centres for Disease Prevention and Control (ECDC)

From: Limited cross-border infections in patients newly diagnosed with HIV in Europe

  Men having Sex with Men(MSM) Heterosexual Injecting drug users
Country SPREAD ECDC Absolute difference SPREAD ECDC Absolute difference SPREAD ECDC Absolute difference
Austria 39.1% 36.9% 2.2% 47.8% 41.1% 6.7% 6.5% 15.2% 8.7%
Belgium 43.5% 27.8% 15.7% 34.4% 40.5% 6.1% 0.9% 2.0% 1.1%
Croatia 60.0% 57.7% 2.3% 20.0% 28.8% 8.8% 13.3% 3.8% 9.5%
Cyprus 49.1% 13.7% 35.4% 45.5% 14.4% 31.1% 0.0% 1.4% 1.4%
Czech Republic 41.8% 63.6% 21.8% 20.0% 23.1% 3.1% 7.7% 9.9% 2.2%
Denmark 44.7% 46.4% 1.7% 45.4% 42.5% 2.9% 5.1% 6.9% 1.8%
Finland 45.3% 36.2% 9.1% 45.3% 40.4% 4.9% 8.4% 6.9% 1.5%
Germany 84.4% 56.0% 28.4% 7.7% 24.1% 16.4% 3.5% 5.5% 2.0%
Greece 67.0% 55.5% 11.5% 21.1% 25.3% 4.2% 2.7% 2.3% 0.4%
Ireland 33.3% 20.5% 12.8% 43.0% 40.7% 2.3% 18.3% 12.8% 5.5%
Israel 39.5% 21.9% 17.6% 46.2% 48.2% 2.0% 13.4% 11.0% 2.4%
Italy 37.6% 25.1% 12.5% 53.3% 49.2% 4.1% 2.5% 8.5% 6.0%
Latvia 8.3% 4.2% 4.1% 33.3% 36.0% 2.7% 38.9% 40.2% 1.3%
Luxembourg 34.6% 36.2% 1.6% 53.8% 38.3% 15.5% 3.8% 14.9% 11.1%
Netherlands 45.4% 62.5% 17.1% 45.4% 30.2% 15.2% 7.2% 1.1% 6.1%
Norway 32.2% 31.0% 1.2% 58.5% 57.3% 1.2% 8.5% 5.2% 3.3%
Poland 37.3% 4.7% 32.6% 28.5% 10.2% 18.3% 26.9% 12.9% 14.0%
Portugal 16.0% 15.0% 1.0% 62.6% 63.5% 0.9% 16.0% 19.4% 3.4%
Romania 14.9% 3.6% 11.3% 53.7% 66.1% 12.4% 3.0% 1.8% 1.2%
Serbia 32.8% 44.0% 11.2% 49.3% 25.3% 24.0% 14.9% 13.2% 1.7%
Slovakia 65.2% 64.1% 1.1% 34.8% 30.8% 4.0% 0.0% 2.6% 2.6%
Slovenia 86.9% 81.1% 5.8% 13.1% 5.4% 7.7% 0.0% 0.0% 0.0%
Spain 53.3% 44.1% 9.2% 27.4% 39.3% 11.9% 8.3% 9.9% 1.6%
Sweden 36.4% 22.0% 14.4% 51.6% 40.7% 10.9% 9.9% 11.6% 1.7%
  1. The numbers may not add up to 100% as the HIV risk group is not always known (most notably this distribution was reported by ECDC for <30% of patients in Cyprus and Poland).